Tickr
Home Explore Daily Brief Market Watchlists Portfolio
Research
Catalysts Signal Factory Screener Market News Event Calendar Valuation Plot Heat Map Top Investors Industry Trends Options
AI Assistant Notifications Account
Grace Therapeutics, Inc. logo

Grace Therapeutics, Inc. (GRCE) Stock Ticker

NASDAQ: GRCE · Healthcare · Biotechnology
$2.12-1.85%
USD · as of 2026-09-27 · market cap $34.5M
Open GRCE in TickrDownload for iPhone

GRCE right now

Options price it to move more than 9 in 10 stocks.
Options expect by Oct 6±13.4%
Options expect by Oct 29±27.8%
Priced in for Nov 12 earnings±33.7%
IV rank (30-day)43% · fair
From Tickr's live models · 2026-09-29. Not investment advice.

Market factors today

Tickr 500 vs S&P 500+0.49%+1.0% MTD
Momentum L/S+1.35%+15.1% MTD
High-beta momo L/S+1.46%+22.2% MTD
Rate sensitivity L/S+1.91%+6.9% MTD
Oil sensitivity L/S-2.54%-5.3% MTD
Unprofitable tech-1.43%+3.7% MTD

Unlock the full GRCE picture

🔒 Implied move chart & probabilities
🔒 Live options flow
🔒 AI analysis & chat on GRCE
🔒 Catalysts & earnings
🔒 Strategy Lab
🔒 Financials & estimates
Start your 7-day free trial

About Grace Therapeutics, Inc.

Grace Therapeutics, Inc. specializes in the creation and commercialization of pharmaceutical products, primarily targeting uncommon and neglected diseases, with operations centered in Canada. The company's most advanced experimental treatment is GTX-104, an intravenous infusion designed to address subarachnoid hemorrhage. Its development pipeline further includes GTX-102, an oral mucosal betamethasone spray intended for the management of ataxia-telangiectasia, and GTX-101, a topical bioadhesive film-forming bupivacaine spray for postherpetic neuralgia. Established in 2002, the enterprise previously operated under the name Acasti Pharma Inc., before officially adopting Grace Therapeutics, Inc. in October 2024. The company's main offices are located in Princeton, New Jersey.

GRCE stock facts

Ticker symbolGRCE
ExchangeNASDAQ Global Market
SectorHealthcare
IndustryBiotechnology
Market cap$34.5M
CEOPrashant Kohli
Employees5
HeadquartersPrinceton, NJ, US
IPO date2012-02-07
Websitewww.gracetx.com

What you can see for GRCE on Tickr

Live GRCE price chart with overlays, the options chain, implied move, IV rank, options flow and Strategy Lab, financial statements and consensus estimates, analyst ratings, catalysts, news with AI scoring, and an AI chat that has read the GRCE report.

Rankings

Largest Healthcare companiesLargest companies by market cap

FAQ

What is the ticker symbol for Grace Therapeutics, Inc.?

The ticker symbol for Grace Therapeutics, Inc. is GRCE, listed on the NASDAQ Global Market.

What is GRCE?

Grace Therapeutics, Inc. specializes in the creation and commercialization of pharmaceutical products, primarily targeting uncommon and neglected diseases, with operations centered in Canada. The company's most advanced experimental treatment is GTX-104, an intravenous infusion designed to address subarachnoid hemorrhage. Its development pipeline further includes GTX-102, an oral mucosal…

HomeExploreMarketLists
All pages